Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Marika Mokou"'
Autor:
Felix Keller, Joachim Beige, Justyna Siwy, Alexandre Mebazaa, Dewei An, Harald Mischak, Joost P. Schanstra, Marika Mokou, Paul Perco, Jan A. Staessen, Antonia Vlahou, Agnieszka Latosinska
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background There is evidence of pre-established vulnerability in individuals that increases the risk of their progression to severe disease or death, although the mechanisms causing this are still not fully understood. Previous research has
Externí odkaz:
https://doaj.org/article/a3cf124b0572411f8e6cda3305979cf0
Autor:
Dimitra Zagoura, Ourania Trohatou, Manousos Makridakis, Antonia Kollia, Nikolitsa Kokla, Marika Mokou, Adriana Psaraki, Aristides G. Eliopoulos, Antonia Vlahou, Maria G. Roubelakis
Publikováno v:
EBioMedicine, Vol 45, Iss , Pp 542-552 (2019)
Background: Human mesenchymal stem/stromal cells (MSCs) and their secreted molecules exert beneficial effects in injured tissues by promoting tissue regeneration and angiogenesis and by inhibiting inflammation and fibrosis. We have previously demonst
Externí odkaz:
https://doaj.org/article/21bff484fcd04d4fb1c4a990f9aba497
Autor:
Marika Mokou, Julie Klein, Manousos Makridakis, Vasiliki Bitsika, Jean-Loup Bascands, Jean Sebastien Saulnier-Blache, William Mullen, Michael Sacherer, Jerome Zoidakis, Burkert Pieske, Harald Mischak, Maria G. Roubelakis, Joost P. Schanstra, Antonia Vlahou
Publikováno v:
EBioMedicine, Vol 41, Iss , Pp 91-104 (2019)
Background: The increased prevalence of cardiovascular disease (CVD) indicates a demand for novel therapeutic approaches. Proteome analysis of vascular tissues from animal models and humans with CVD could lead to the identification of novel druggable
Externí odkaz:
https://doaj.org/article/839a068c0692417e930ff08a97b6c677
Publikováno v:
Expert Review of Molecular Diagnostics. 23:187-189
Autor:
Felix Keller, Joachim Beige, Justyna Siwy, Alexandre Mebazaa, Dewei An, Harald Mischak, Joost P. Schanstra, Marika Mokou, Paul Perco, Jan A. Staessen, Antonia Vlahou, Agnieszka Latosinska
SummaryCOV50, a urinary proteomic classifier, predicts disease progression and death from SARS-CoV-2 at early stage, suggesting it might predict pre-established vulnerability. This study investigated the value of COV50 in predicting non-COVID-19 asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cceb7fe90dc93e17d202a38bb29c2539
https://doi.org/10.1101/2023.04.28.23289257
https://doi.org/10.1101/2023.04.28.23289257
Autor:
Maria Frantzi, Zoran Culig, Isabel Heidegger, Marika Mokou, Agnieszka Latosinska, Marie C. Roesch, Axel S. Merseburger, Manousos Makridakis, Antonia Vlahou, Ana Blanca-Pedregosa, Julia Carrasco-Valiente, Harald Mischak, Enrique Gomez-Gomez
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1166
Volume 15
Issue 4
Pages: 1166
(1) Background: Prostate cancer (PCa) is the most frequently diagnosed cancer in men. Wide application of prostate specific antigen test has historically led to over-treatment, starting from excessive biopsies. Risk calculators based on molecular and
Autor:
Rafael Stroggilos, Maria Frantzi, Jerome Zoidakis, Marika Mokou, Napoleon Moulavasilis, Emmanouil Mavrogeorgis, Anna Melidi, Manousos Makridakis, Konstantinos Stravodimos, Maria G. Roubelakis, Harald Mischak, Antonia Vlahou
Publikováno v:
Cancers (Basel)
Cancers; Volume 14; Issue 10; Pages: 2542
Cancers; Volume 14; Issue 10; Pages: 2542
Despite advancements in molecular classification, tumor stage and grade still remain the most relevant prognosticators used by clinicians to decide on patient management. Here, we leverage publicly available data to characterize bladder cancer (BLCA)
Autor:
Lourdes Mengual, Maria Frantzi, Marika Mokou, Mercedes Ingelmo-Torres, Michiel Vlaming, Axel S. Merseburger, Marie C. Roesch, Zoran Culig, Antonio Alcaraz, Antonia Vlahou, Harald Mischak, Antoine G. Van der Heijden
Publikováno v:
British Journal of Cancer, 127, 11, pp. 2043-2051
British Journal of Cancer, 127, 2043-2051
British Journal of Cancer, 127, 2043-2051
Non-invasive urine-based biomarkers can potentially improve current diagnostic and monitoring protocols for bladder cancer (BC). Here we assess the performance of earlier published biomarker panels for BC detection (BC-116) and monitoring of recurren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28e37a8a6c62e87c455b611cd8ba676a
https://repository.ubn.ru.nl/handle/2066/285993
https://repository.ubn.ru.nl/handle/2066/285993
Autor:
Lourdes Mengual, Maria Frantzi, Marika Mokou, Mercedes Ingelmo-Torres, Michiel Vlaming, Axel S. Merseburger, Marie C. Roesch, Zoran Culig, Antonio Alcaraz, Antonia Vlahou, Harald Mischak, Antoine G. Van der Heijden
PurposeNon-invasive urine-based biomarkers for bladder cancer (BC) diagnosis and surveillance can potentially improve current diagnostic and monitoring protocols by guiding cystoscopy. Here, we aim to access the diagnostic performance of nomograms ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb05729c7945d35fb265b30e5c528650
https://doi.org/10.1101/2021.12.15.21267846
https://doi.org/10.1101/2021.12.15.21267846
Autor:
Antonia Vlahou, Emmanouil Mavrogeorgis, Rafael Stroggilos, Jerome Zoidakis, Harald Mischak, Maria G. Roubelakis, Maria Frantzi, Marika Mokou
Despite advancements in therapeutics, Bladder Cancer (BLCA) constitutes a major clinical burden, with locally advanced and metastatic cases facing poor survival rates. Aiming at expanding our knowledge of BLCA molecular pathophysiology, we integrated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3ebfc318dcd61bf2fedcb7a641fbca1
https://doi.org/10.1101/2021.06.15.21258890
https://doi.org/10.1101/2021.06.15.21258890